Literature DB >> 20852041

Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene.

Matthew J Durand1, Carol Moreno, Andrew S Greene, Julian H Lombard.   

Abstract

This study evaluated endothelium-dependent vascular relaxation in response to acetylcholine (ACh) in isolated middle cerebral arteries (MCA) from Dahl salt-sensitive (Dahl SS) rats and three different congenic strains that contain a portion of Brown Norway (BN) chromosome 13 introgressed onto the Dahl SS genetic background through marker-assisted breeding. Two of the congenic strains carry a 3.5-Mbp portion and a 2.6-Mbp portion of chromosome 13 that lie on opposite sides of the renin locus, while the third contains a 2.0-Mbp overlapping region that includes the BN renin allele. While maintained on a normal salt (0.4% NaCl) diet, MCAs from Dahl SS rats and the congenic strains retaining the Dahl SS renin allele failed to dilate in response to ACh, whereas MCAs from the congenic strain carrying the BN renin allele exhibited normal vascular relaxation. In congenic rats receiving the BN renin allele, vasodilator responses to ACh were eliminated by nitric oxide synthase inhibition with N(G)-nitro-l-arginine methyl ester, angiotensin-converting enzyme inhibition with captopril, and AT(1) receptor blockade with losartan. N(G)-nitro-l-arginine methyl ester-sensitive vasodilation in response to ACh was restored in MCAs of Dahl SS rats that received either a 3-day infusion of a subpressor dose of angiotensin II (3 ng·kg(-1)·min(-1) iv), or chronic treatment with the superoxide dismutase mimetic tempol (15 mg·kg(-1)·day(-1)). These findings indicate that the presence of the Dahl SS renin allele plays a crucial role in endothelial dysfunction present in the cerebral circulation of the Dahl SS rat, even in the absence of elevated dietary salt intake, and that introgression of the BN renin allele rescues endothelium-dependent vasodilator responses by restoring normal activation of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852041      PMCID: PMC3006280          DOI: 10.1152/ajpheart.00700.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  58 in total

1.  Reduced angiotensin II and oxidative stress contribute to impaired vasodilation in Dahl salt-sensitive rats on low-salt diet.

Authors:  Ines Drenjancevic-Peric; Julian H Lombard
Journal:  Hypertension       Date:  2005-02-14       Impact factor: 10.190

2.  Transfer of a salt-resistant renin allele raises blood pressure in Dahl salt-sensitive rats.

Authors:  J Jiang; D E Stec; H Drummond; J S Simon; G Koike; H J Jacob; R J Roman
Journal:  Hypertension       Date:  1997-02       Impact factor: 10.190

3.  Impairment of endothelial function in salt-sensitive hypertension in humans.

Authors:  A Miyoshi; H Suzuki; M Fujiwara; M Masai; T Iwasaki
Journal:  Am J Hypertens       Date:  1997-10       Impact factor: 2.689

4.  Abnormal flow-mediated epicardial vasomotion in human coronary arteries is improved by angiotensin-converting enzyme inhibition: a potential role of bradykinin.

Authors:  A Prasad; S Husain; A A Quyyumi
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

5.  Chronic At1 receptor blockade alters the mechanisms mediating hypoxic dilation in middle cerebral arteries.

Authors:  Shane A Phillips; Julian H Lombard
Journal:  J Cardiovasc Pharmacol       Date:  2005-11       Impact factor: 3.105

6.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.

Authors:  S Rajagopalan; S Kurz; T Münzel; M Tarpey; B A Freeman; K K Griendling; D G Harrison
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

7.  Chromosomal substitution-dependent differences in cardiovascular responses to sodium pentobarbital.

Authors:  Thomas A Stekiel; Stephen J Contney; Zeljko J Bosnjak; John P Kampine; Richard J Roman; William J Stekiel
Journal:  Anesth Analg       Date:  2006-03       Impact factor: 5.108

8.  Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. The Trandolapril Multicenter Study Group.

Authors:  M R Weir; J M Gray; R Paster; E Saunders
Journal:  Hypertension       Date:  1995-07       Impact factor: 10.190

Review 9.  Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature.

Authors:  Hidekatsu Nakashima; Hiroyuki Suzuki; Haruhiko Ohtsu; James Y Chao; Hirotoshi Utsunomiya; Gerald D Frank; Satoru Eguchi
Journal:  Curr Vasc Pharmacol       Date:  2006-01       Impact factor: 2.719

10.  Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients.

Authors:  George L Bakris; David Hg Smith; Thomas D Giles; William B White; Giora Davidai; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-10       Impact factor: 3.738

View more
  15 in total

Review 1.  Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat.

Authors:  Kathleen M Lukaszewicz; Julian H Lombard
Journal:  Clin Sci (Lond)       Date:  2013-06       Impact factor: 6.124

2.  Evaluation of Vascular Control Mechanisms Utilizing Video Microscopy of Isolated Resistance Arteries of Rats.

Authors:  Kathleen M Lukaszewicz; Matthew J Durand; Jessica R C Priestley; James R Schmidt; L Adrienne Allen; Aron M Geurts; Julian H Lombard
Journal:  J Vis Exp       Date:  2017-12-05       Impact factor: 1.355

3.  Introgression of Brown Norway CYP4A genes on to the Dahl salt-sensitive background restores vascular function in SS-5(BN) consomic rats.

Authors:  Kathleen M Lukaszewicz; John R Falck; Vijaya L Manthati; Julian H Lombard
Journal:  Clin Sci (Lond)       Date:  2013-03       Impact factor: 6.124

4.  Enhancement of resting-state fcMRI networks by prior sensory stimulation.

Authors:  Chenxuan Li; Zhixin Li; B Douglas Ward; Melinda R Dwinell; Julian H Lombard; Anthony G Hudetz; Christopher P Pawela
Journal:  Brain Connect       Date:  2014-11

5.  Role of vascular reactive oxygen species in regulating cytochrome P450-4A enzyme expression in Dahl salt-sensitive rats.

Authors:  Kathleen M Lukaszewicz; Mahesh P Paudyal; John R Falck; Julian H Lombard
Journal:  Microcirculation       Date:  2016-10       Impact factor: 2.628

6.  Dahl salt-sensitive rats are protected against vascular defects related to diet-induced obesity.

Authors:  Andreas M Beyer; Gabor Raffai; Brian Weinberg; Katherine Fredrich; Julian H Lombard
Journal:  Hypertension       Date:  2012-06-18       Impact factor: 10.190

7.  Amelioration of salt-induced vascular dysfunction in mesenteric arteries of Dahl salt-sensitive rats by missense mutation of extracellular superoxide dismutase.

Authors:  Andreas M Beyer; Gabor Raffai; Brian D Weinberg; Katherine Fredrich; Matthew S Rodgers; Aron M Geurts; Howard J Jacob; Melinda R Dwinell; Julian H Lombard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-12-06       Impact factor: 4.733

8.  High salt diet impairs cerebral blood flow regulation via salt-induced angiotensin II suppression.

Authors:  Linda A Allen; James R Schmidt; Christopher T Thompson; Brian E Carlson; Daniel A Beard; Julian H Lombard
Journal:  Microcirculation       Date:  2019-01-15       Impact factor: 2.628

9.  Low-dose angiotensin II infusion restores vascular function in cerebral arteries of high salt-fed rats by increasing copper/zinc superoxide dimutase expression.

Authors:  Matthew J Durand; Julian H Lombard
Journal:  Am J Hypertens       Date:  2013-02-26       Impact factor: 2.689

10.  AT1 receptors prevent salt-induced vascular dysfunction in isolated middle cerebral arteries of 2 kidney-1 clip hypertensive rats.

Authors:  Andreas M Beyer; Katherine Fredrich; Julian H Lombard
Journal:  Am J Hypertens       Date:  2013-08-09       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.